We are live on ! Find out more
CGH

Crossmark Global Holdings Portfolio holdings

AUM $7.71B
1-Year Est. Return 37.66%
This Fund
S&P 500
This Quarter Est. Return
+11.26%
1 Year Est. Return
+37.66%
3 Year Est. Return
+112.26%
5 Year Est. Return
+139.33%
10 Year Est. Return
AUM
$4.01B
AUM Growth
+$408M
Cap. Flow
+$69.4M
Cap. Flow %
1.73%
Top 10 Hldgs %
14.06%
Holding
1,291
New
51
Increased
572
Reduced
609
Closed
39

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$11.7M
2
JPM icon
JPMorgan Chase
JPM
+$11.4M
3
KMB icon
Kimberly-Clark
KMB
+$10.8M
4
CVS icon
CVS Health
CVS
+$10.5M
5
SAP icon
SAP
SAP
+$9.82M

Sector Composition

Rank Sector Weight
1 Technology 22.85%
2 Financials 15.32%
3 Healthcare 13.19%
4 Consumer Discretionary 10.16%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTH icon
1076
Meritage Homes
MTH
$4.71B
$261K 0.01%
5,654
-484
-8% -$19.6K
SPT icon
1077
Sprout Social
SPT
$492M
$261K 0.01%
4,630
+370
+9% +$21.7K
VYX icon
1078
NCR Voyix
VYX
$1.16B
$261K 0.01%
18,166
-220
-1% -$2.93K
AEIS icon
1079
Advanced Energy
AEIS
$13B
$259K 0.01%
3,020
-202
-6% -$17K
ELF icon
1080
e.l.f. Beauty
ELF
$5.44B
$259K 0.01%
+4,685
New +$229K
SPXC icon
1081
SPX Corp
SPXC
$10.7B
$259K 0.01%
3,956
-274
-6% -$17.9K
ICUI icon
1082
ICU Medical
ICUI
$4.16B
$258K 0.01%
1,639
-356
-18% -$54.2K
EYE icon
1083
National Vision
EYE
$1.8B
$257K 0.01%
6,629
+349
+6% +$13.1K
VNT icon
1084
Vontier
VNT
$4.97B
$257K 0.01%
13,331
-1,190
-8% -$22.3K
NARI
1085
DELISTED
Inari Medical, Inc. Common Stock
NARI
$257K 0.01%
4,049
+229
+6% +$16.6K
PPBI
1086
DELISTED
Pacific Premier Bancorp
PPBI
$256K 0.01%
8,137
-424
-5% -$14.6K
CWEN icon
1087
Clearway Energy Class C
CWEN
$6.74B
$255K 0.01%
8,012
-1,958
-20% -$66K
NWE icon
1088
NorthWestern Energy
NWE
$4.32B
$254K 0.01%
4,278
-52
-1% -$2.84K
AJRD
1089
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$254K 0.01%
4,550
-450
-9% -$22.3K
DOCN icon
1090
DigitalOcean
DOCN
$14.4B
$253K 0.01%
9,923
+919
+10% +$28.8K
MTSI icon
1091
MACOM Technology Solutions
MTSI
$23B
$252K 0.01%
+4,000
New +$250K
BDC icon
1092
Belden
BDC
$5.05B
$251K 0.01%
3,492
-48
-1% -$3.48K
VNO icon
1093
Vornado Realty Trust
VNO
$7.27B
$251K 0.01%
12,037
+2,357
+24% +$54K
COTY icon
1094
Coty
COTY
$2.39B
$250K 0.01%
29,182
-490
-2% -$3.6K
KFY icon
1095
Korn Ferry
KFY
$4.2B
$250K 0.01%
4,934
-2,536
-34% -$135K
CABO icon
1096
Cable One
CABO
$252M
$249K 0.01%
349
-77
-18% -$57.4K
ADNT icon
1097
Adient
ADNT
$1.45B
$247K 0.01%
7,099
-381
-5% -$13.3K
KMPR icon
1098
Kemper
KMPR
$1.76B
$246K 0.01%
5,000
-58
-1% -$2.92K
KSS icon
1099
Kohl's
KSS
$2.09B
$246K 0.01%
9,732
-1,190
-11% -$33.7K
TNDM icon
1100
Tandem Diabetes Care
TNDM
$1.29B
$245K 0.01%
5,436
-397
-7% -$18K

Similar funds

Crossmark Global Holdings's Q4 2022 Portfolio in Review

As of Q4 2022, Crossmark Global Holdings held 1,291 positions worth $4.01B, up 11% from $3.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Crossmark Global Holdings's Q4 2022 filing shows 51 new, 572 increased, 609 reduced and 39 closed positions. Its largest new stake was Berry Global Group, Inc.: 28,856 shares worth $1.6M. The largest sale was Intel, an estimated $11.7M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

  • Crossmark Global Holdings's largest Q4 2022 buy was Berry Global Group, Inc.: 28,856 shares worth $1.6M.
  • Crossmark Global Holdings added most to Accenture in Q4 2022, an estimated $11.5M increase.
  • Crossmark Global Holdings's biggest Q4 2022 reduction was Intel, cutting an estimated $11.7M.
  • Crossmark Global Holdings fully exited CEMIG Preferred Shares in Q4 2022, selling an estimated $7.14M.
  • Crossmark Global Holdings's ten largest holdings make up 14% of its $4.01B portfolio in Q4 2022.
  • Crossmark Global Holdings opened 51 new positions and closed 39 in Q4 2022.
  • Crossmark Global Holdings's portfolio value rose 11% quarter-over-quarter to $4.01B.

Based on Crossmark Global Holdings's 13F filing for Q4 2022, filed 19 Jan 2023.